Medicine and Dentistry
Human Immunodeficiency Virus
70%
Health
45%
Prevalence
20%
Antiretroviral Therapy
8%
Darunavir
8%
Association
8%
Adult
8%
Cross Sectional Study
8%
Obesity
4%
Metabolic Syndrome
4%
Stavudine
4%
Zidovudine
4%
Smoking
4%
Population
4%
Cholesterol
4%
Cohort Analysis
4%
Water-Electrolyte Imbalance
4%
Human Immunodeficiency Virus Infection
4%
Deterioration
4%
Reverse-Transcriptase Inhibitor
4%
Hepatitis C
4%
Thymidine
4%
Age
4%
Therapeutic Procedure
4%
Race
4%
Experience
4%
Nursing and Health Professions
Man
100%
Prevalence
20%
Antiretroviral Therapy
8%
Darunavir
8%
Obesity
4%
Cholesterol
4%
Population
4%
Human Immunodeficiency Virus Infection
4%
Cohort Analysis
4%
Deterioration
4%
Metabolic Syndrome X
4%
Hepatitis C
4%
Zidovudine
4%
Metabolic Disorder
4%
Stavudine
4%
RNA Directed DNA Polymerase Inhibitor
4%
Procedures
4%
Variance
4%
Thymidine
4%
INIS
hiv
75%
men
50%
therapy
8%
design
4%
obesity
4%
education
4%
adults
4%
populations
4%
disturbances
4%
spectra
4%
hepatitis
4%
viruses
4%
panels
4%
cholesterol
4%
AIDS
4%
nucleosides
4%
thymidine
4%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
70%
Prevalence
20%
Darunavir
8%
Deterioration
4%
Human Immunodeficiency Virus Infection
4%
Zidovudine
4%
Cholesterol
4%
Obesity
4%
Stavudine
4%
RNA Directed DNA Polymerase Inhibitor
4%
Hepatitis C
4%
Thymidine
4%
Metabolic Disorder
4%
Metabolic Syndrome X
4%